ConductScience.org, home

Trial · NCT05279833

Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation

NCT05279833, Completed, Sanofi

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation. Trials, record NCT05279833. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05279833

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
NCT number
NCT05279833
Status
Completed
Enrollment
87,810 participants, actual
Lead sponsor
Sanofi
Conditions
Atrial Fibrillation
Interventions
dronedarone, sotalol
First posted
2022-03-15
Last updated
2024-01-09

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of participants with Cardiovascular (CV) hospitalizationAs reported in studies included in the systematic review up to 10 yearsCV hospitalization is defined as composite of heart failure hospitalization, AFib hospitalization, MI, and stroke
PrimaryNumber of participants with ventricular proarrhythmiaAs reported in studies included in the systematic review up to 10 years
PrimaryNumber of all-cause mortality eventsAs reported in studies included in the systematic review up to 10 years
PrimaryNumber of cardiovascular mortality eventsAs reported in studies included in the systematic review up to 10 yearsincludes arrhythmia-related mortality
PrimaryNumber of participants with atrial fibrillation (AFib) recurrenceAs reported in studies included in the systematic review up to 10 years
SecondaryNumber of participants with myocardial infarctionAs reported in studies included in the systematic review up to 10 years
SecondaryNumber of participants with strokeAs reported in studies included in the systematic review up to 10 years
SecondaryNumber of participants with heart failure hospitalizationAs reported in studies included in the systematic review up to 10 years
SecondaryNumber of participants with AFib hospitalizationAs reported in studies included in the systematic review up to 10 years
SecondaryNumber of participants with conduction disordersAs reported in studies included in the systematic review up to 10 yearsAtrioventricular block (2nd or 3rd degree) or Requirement of pacemaker implants

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
37025083RESULT

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05279833

GET https://conductscience.org/api/trials/v1/NCT05279833/registered